세계의 에녹사파린 원료의약품 시장(2025년)

Global Enoxaparin API market size in terms of revenue is projected to reach 287.08 million USD by 2031 from 171.30 million USD in 2024, with a CAGR 5.38% during 2025-2031.

North America market for Enoxaparin API is estimated to increase from 28.17 million USD in 2024 to reach 40.23 million USD by 2031, at a CAGR of 3.86% during the forecast period of 2025 through 2031.

Europe market for Enoxaparin API is estimated to increase from 94.34 million USD in 2024 to reach 153.91 million USD by 2031, at a CAGR of 4.68% during the forecast period of 2025 through 2031.

Asia-Pacific market for Enoxaparin API is estimated to increase from 40.34 million USD in 2024 to reach 77.75 million USD by 2031, at a CAGR of 7.46% during the forecast period of 2025 through 2031.

The major global manufacturers of Enoxaparin API include Hepalink, Yantai Dongcheng Pharmaceutical, Changzhou Qianhong Biopharma, Hebei Changshan Biochemical Pharmaceutical, Hubei Enoray Biopharmaceutical (Tianjin Chasesun Pharmaceutical), Chongqing Yino Pharma, Chengdu Baiyu Pharmaceutical, Haike Group, Jiangxi Haoran Bio-Pharma, Shandong Chenlong Pharmaceutical (Cisen Pharmaceutical), etc. In 2024, the world's top five vendors accounted for approximately 69.88% of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Enoxaparin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enoxaparin API.

The Enoxaparin API market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Enoxaparin API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Enoxaparin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

• Hepalink
• Yantai Dongcheng Pharmaceutical
• Changzhou Qianhong Biopharma
• Hebei Changshan Biochemical Pharmaceutical
• Hubei Enoray Biopharmaceutical (Tianjin Chasesun Pharmaceutical)
• Chongqing Yino Pharma
• Chengdu Baiyu Pharmaceutical
• Haike Group
• Jiangxi Haoran Bio-Pharma
• Shandong Chenlong Pharmaceutical (Cisen Pharmaceutical)
• Stanex

Segment by Anti-factor Xa Activity

• Above 100 IU/mg
• Below 100 IU/mg

Segment by Application

• 0.2ml:2000IU
• 0.4ml:4000IU
• 0.6ml:6000IU
• 0.8ml:8000IU
• 1ml:10000IU
• Others

Production by Region

• North America
• Europe
• China
• India

Consumption by Region

• North America
• U.S.
• Canada
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• U.K.
• Italy
• Spain
• Rest of Europe
• Latin America
• Mexico
• Brazil
• Middle East & Africa

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Enoxaparin API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Production/output, value of Enoxaparin API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 4: Consumption of Enoxaparin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: The main points and conclusions of the report.

Table of Contents

1 Enoxaparin API Market Overview

• 1.1 Product Definition
• 1.2 Enoxaparin API by Anti-factor Xa Activity
  • 1.2.1 Global Enoxaparin API Market Value Growth Rate Analysis by Anti-factor Xa Activity: 2024 VS 2031
  • 1.2.2 Above 100 IU/mg
  • 1.2.3 Below 100 IU/mg
• 1.3 Enoxaparin API by Application
  • 1.3.1 Global Enoxaparin API Market Value Growth Rate Analysis by Application: 2024 VS 2031
  • 1.3.2 0.2ml:2000IU
  • 1.3.3 0.4ml:4000IU
  • 1.3.4 0.6ml:6000IU
  • 1.3.5 0.8ml:8000IU
  • 1.3.6 1ml:10000IU
  • 1.3.7 Others
• 1.4 Global Market Growth Prospects
  • 1.4.1 Global Enoxaparin API Production Value Estimates and Forecasts (2020-2031)
  • 1.4.2 Global Enoxaparin API Production Capacity Estimates and Forecasts (2020-2031)
  • 1.4.3 Global Enoxaparin API Production Estimates and Forecasts (2020-2031)
  • 1.4.4 Global Enoxaparin API Market Average Price Estimates and Forecasts (2020-2031)
• 1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

• 2.1 Global Enoxaparin API Production Market Share by Manufacturers (2020-2025)
• 2.2 Global Enoxaparin API Production Value Market Share by Manufacturers (2020-2025)
• 2.3 Global Key Players of Enoxaparin API, Industry Ranking, 2023 VS 2024
• 2.4 Global Enoxaparin API Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 2.5 Global Enoxaparin API Average Price by Manufacturers (2020-2025)
• 2.6 Global Key Manufacturers of Enoxaparin API, Manufacturing Sites & Headquarters
• 2.7 Global Key Manufacturers of Enoxaparin API, Product Type & Application
• 2.8 Global Key Manufacturers of Enoxaparin API, Date of Enter into This Industry
• 2.9 Global Enoxaparin API Market Competitive Situation and Trends
  • 2.9.1 Global Enoxaparin API Market Concentration Rate
  • 2.9.2 Global 5 and 10 Largest Enoxaparin API Players Market Share by Revenue
• 2.10 Mergers & Acquisitions, Expansion

3 Enoxaparin API Production by Region

• 3.1 Global Enoxaparin API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
• 3.2 Global Enoxaparin API Production Value by Region (2020-2031)
  • 3.2.1 Global Enoxaparin API Production Value Market Share by Region (2020-2025)
  • 3.2.2 Global Forecasted Production Value of Enoxaparin API by Region (2026-2031)
• 3.3 Global Enoxaparin API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
• 3.4 Global Enoxaparin API Production by Region (2020-2031)
  • 3.4.1 Global Enoxaparin API Production Market Share by Region (2020-2025)
  • 3.4.2 Global Forecasted Production of Enoxaparin API by Region (2026-2031)
• 3.5 Global Enoxaparin API Market Price Analysis by Region (2020-2025)
• 3.6 Global Enoxaparin API Production and Value, Year-over-Year Growth
  • 3.6.1 North America Enoxaparin API Production Value Estimates and Forecasts (2020-2031)
  • 3.6.2 Europe Enoxaparin API Production Value Estimates and Forecasts (2020-2031)
  • 3.6.3 China Enoxaparin API Production Value Estimates and Forecasts (2020-2031)
  • 3.6.4 India Enoxaparin API Production Value Estimates and Forecasts (2020-2031)

4 Enoxaparin API Consumption by Region

• 4.1 Global Enoxaparin API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
• 4.2 Global Enoxaparin API Consumption by Region (2020-2031)
  • 4.2.1 Global Enoxaparin API Consumption by Region (2020-2031)
  • 4.2.2 Global Enoxaparin API Forecasted Consumption by Region (2026-2031)
• 4.3 North America
  • 4.3.1 North America Enoxaparin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
  • 4.3.2 North America Enoxaparin API Consumption by Country (2020-2031)
  • 4.3.3 U.S.
  • 4.3.4 Canada
• 4.4 Europe
  • 4.4.1 Europe Enoxaparin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
  • 4.4.2 Europe Enoxaparin API Consumption by Country (2020-2031)
  • 4.4.3 Germany
  • 4.4.4 France
  • 4.4.5 U.K.
  • 4.4.6 Italy
  • 4.4.7 Spain
• 4.5 Asia Pacific
  • 4.5.1 Asia Pacific Enoxaparin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
  • 4.5.2 Asia Pacific Enoxaparin API Consumption by Region (2020-2031)
  • 4.5.3 China
  • 4.5.4 Japan
  • 4.5.5 South Korea
  • 4.5.6 Southeast Asia
  • 4.5.7 India
  • 4.5.8 Australia
• 4.6 Latin America
  • 4.6.1 Latin America Enoxaparin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
  • 4.6.2 Latin America Enoxaparin API Consumption by Country (2020-2031)
  • 4.6.3 Mexico
  • 4.6.4 Brazil
• 4.7 Middle East and Africa

5 Segment by Anti-factor Xa Activity

• 5.1 Global Enoxaparin API Production by Anti-factor Xa Activity (2020-2031)
  • 5.1.1 Global Enoxaparin API Production by Anti-factor Xa Activity (2020-2025)
  • 5.1.2 Global Enoxaparin API Production by Anti-factor Xa Activity (2026-2031)
  • 5.1.3 Global Enoxaparin API Production Market Share by Anti-factor Xa Activity (2020-2031)
• 5.2 Global Enoxaparin API Production Value by Anti-factor Xa Activity (2020-2031)
  • 5.2.1 Global Enoxaparin API Production Value by Anti-factor Xa Activity (2020-2025)
  • 5.2.2 Global Enoxaparin API Production Value by Anti-factor Xa Activity (2026-2031)
  • 5.2.3 Global Enoxaparin API Production Value Market Share by Anti-factor Xa Activity (2020-2031)
• 5.3 Global Enoxaparin API Price by Anti-factor Xa Activity (2020-2031)

6 Segment by Application

• 6.1 Global Enoxaparin API Production by Application (2020-2031)
  • 6.1.1 Global Enoxaparin API Production by Application (2020-2025)
  • 6.1.2 Global Enoxaparin API Production by Application (2026-2031)
  • 6.1.3 Global Enoxaparin API Production Market Share by Application (2020-2031)
• 6.2 Global Enoxaparin API Production Value by Application (2020-2031)
  • 6.2.1 Global Enoxaparin API Production Value by Application (2020-2025)
  • 6.2.2 Global Enoxaparin API Production Value by Application (2026-2031)
  • 6.2.3 Global Enoxaparin API Production Value Market Share by Application (2020-2031)
• 6.3 Global Enoxaparin API Price by Application (2020-2031)

7 Key Companies Profiled

• 7.1 Hepalink
  • 7.1.1 Hepalink Enoxaparin API Company Information
  • 7.1.2 Hepalink Enoxaparin API Product Portfolio
  • 7.1.3 Hepalink Enoxaparin API Production, Value, Price and Gross Margin (2020-2025)
  • 7.1.4 Hepalink Main Business and Markets Served
  • 7.1.5 Hepalink Recent Developments/Updates
• 7.2 Yantai Dongcheng Pharmaceutical
  • 7.2.1 Yantai Dongcheng Pharmaceutical Enoxaparin API Company Information
  • 7.2.2 Yantai Dongcheng Pharmaceutical Enoxaparin API Product Portfolio
  • 7.2.3 Yantai Dongcheng Pharmaceutical Enoxaparin API Production, Value, Price and Gross Margin (2020-2025)
  • 7.2.4 Yantai Dongcheng Pharmaceutical Main Business and Markets Served
  • 7.2.5 Yantai Dongcheng Pharmaceutical Recent Developments/Updates
• 7.3 Changzhou Qianhong Biopharma
  • 7.3.1 Changzhou Qianhong Biopharma Enoxaparin API Company Information
  • 7.3.2 Changzhou Qianhong Biopharma Enoxaparin API Product Portfolio
  • 7.3.3 Changzhou Qianhong Biopharma Enoxaparin API Production, Value, Price and Gross Margin (2020-2025)
  • 7.3.4 Changzhou Qianhong Biopharma Main Business and Markets Served
  • 7.3.5 Changzhou Qianhong Biopharma Recent Developments/Updates
• 7.4 Hebei Changshan Biochemical Pharmaceutical
  • 7.4.1 Hebei Changshan Biochemical Pharmaceutical Enoxaparin API Company Information
  • 7.4.2 Hebei Changshan Biochemical Pharmaceutical Enoxaparin API Product Portfolio
  • 7.4.3 Hebei Changshan Biochemical Pharmaceutical Enoxaparin API Production, Value, Price and Gross Margin (2020-2025)
  • 7.4.4 Hebei Changshan Biochemical Pharmaceutical Main Business and Markets Served
  • 7.4.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments/Updates
• 7.5 Hubei Enoray Biopharmaceutical (Tianjin Chasesun Pharmaceutical)
  • 7.5.1 Hubei Enoray Biopharmaceutical (Tianjin Chasesun Pharmaceutical) Enoxaparin API Company Information
  • 7.5.2 Hubei Enoray Biopharmaceutical (Tianjin Chasesun Pharmaceutical) Enoxaparin API Product Portfolio
  • 7.5.3 Hubei Enoray Biopharmaceutical (Tianjin Chasesun Pharmaceutical) Enoxaparin API Production, Value, Price and Gross Margin (2020-2025)
  • 7.5.4 Hubei Enoray Biopharmaceutical (Tianjin Chasesun Pharmaceutical) Main Business and Markets Served
• 7.6 Chongqing Yino Pharma
  • 7.6.1 Chongqing Yino Pharma Enoxaparin API Company Information
  • 7.6.2 Chongqing Yino Pharma Enoxaparin API Product Portfolio
  • 7.6.3 Chongqing Yino Pharma Enoxaparin API Production, Value, Price and Gross Margin (2020-2025)
  • 7.6.4 Chongqing Yino Pharma Main Business and Markets Served
• 7.7 Chengdu Baiyu Pharmaceutical
  • 7.7.1 Chengdu Baiyu Pharmaceutical Enoxaparin API Company Information
  • 7.7.2 Chengdu Baiyu Pharmaceutical Enoxaparin API Product Portfolio
  • 7.7.3 Chengdu Baiyu Pharmaceutical Enoxaparin API Production, Value, Price and Gross Margin (2020-2025)
  • 7.7.4 Chengdu Baiyu Pharmaceutical Main Business and Markets Served
  • 7.7.5 Chengdu Baiyu Pharmaceutical Recent Developments/Updates
• 7.8 Haike Group
  • 7.8.1 Haike Group Enoxaparin API Company Information
  • 7.8.2 Haike Group Enoxaparin API Product Portfolio
  • 7.8.3 Haike Group Enoxaparin API Production, Value, Price and Gross Margin (2020-2025)
  • 7.8.4 Haike Group Main Business and Markets Served
• 7.9 Jiangxi Haoran Bio-Pharma
  • 7.9.1 Jiangxi Haoran Bio-Pharma Enoxaparin API Company Information
  • 7.9.2 Jiangxi Haoran Bio-Pharma Enoxaparin API Product Portfolio
  • 7.9.3 Jiangxi Haoran Bio-Pharma Enoxaparin API Production, Value, Price and Gross Margin (2020-2025)
  • 7.9.4 Jiangxi Haoran Bio-Pharma Main Business and Markets Served
• 7.10 Shandong Chenlong Pharmaceutical (Cisen Pharmaceutical)
  • 7.10.1 Shandong Chenlong Pharmaceutical (Cisen Pharmaceutical) Enoxaparin API Company Information
  • 7.10.2 Shandong Chenlong Pharmaceutical (Cisen Pharmaceutical) Enoxaparin API Product Portfolio
  • 7.10.3 Shandong Chenlong Pharmaceutical (Cisen Pharmaceutical) Enoxaparin API Production, Value, Price and Gross Margin (2020-2025)
  • 7.10.4 Shandong Chenlong Pharmaceutical (Cisen Pharmaceutical) Main Business and Markets Served
  • 7.10.5 Shandong Chenlong Pharmaceutical (Cisen Pharmaceutical) Recent Developments/Updates
• 7.11 Stanex
  • 7.11.1 Stanex Enoxaparin API Company Information
  • 7.11.2 Stanex Enoxaparin API Product Portfolio
  • 7.11.3 Stanex Enoxaparin API Production, Value, Price and Gross Margin (2020-2025)
  • 7.11.4 Stanex Main Business and Markets Served

8 Industry Chain and Sales Channels Analysis

• 8.1 Enoxaparin API Industry Chain Analysis
• 8.2 Enoxaparin API Raw Material Supply Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
• 8.3 Enoxaparin API Production Mode & Process Analysis
• 8.4 Enoxaparin API Sales and Marketing
  • 8.4.1 Enoxaparin API Sales Channels
  • 8.4.2 Enoxaparin API Distributors
• 8.5 Enoxaparin API Customer Analysis

9 Enoxaparin API Market Dynamics

• 9.1 Enoxaparin API Industry Trends
• 9.2 Enoxaparin API Market Drivers
• 9.3 Enoxaparin API Market Challenges
• 9.4 Enoxaparin API Market Restraints

10 Research Findings and Conclusion

11 Methodology and Data Source

• 11.1 Methodology/Research Approach
  • 11.1.1 Research Programs/Design
  • 11.1.2 Market Size Estimation
  • 11.1.3 Market Breakdown and Data Triangulation
• 11.2 Data Source
  • 11.2.1 Secondary Sources
  • 11.2.2 Primary Sources
• 11.3 Author List
• 11.4 Disclaimer 111